St. Louis-based BJC Health System reported a $335.5 million operating gain (3.8% margin) for the nine months ended Sept. 30, up from a $136.1 million operating gain (1.8% margin) in the same period last year, according to financial documents released published Nov. 14
Five things to know:
1. Total operating revenue rose to $8.9 billion for the nine-month period, up from $7.8 billion in the same period last year. Net patient revenue accounted for $8.1 billion, while other operating revenue reached $737 million.
2. Operating expenses increased to $8.6 billion, up from $7.6 billion year over year. The largest costs were salaries and benefits ($4.1 billion), supplies ($2.2 billion), and affiliation agreements and purchased services with Washington University School of Medicine ($599 million combined).
3. After accounting for nonoperating items, such as investment returns, BJC reported a net income of $1.1 billion, down from $2.5 billion in the same period in 2024.
4. Cash and investments reached $9.2 billion as of Sept. 30, up from $8.3 billion at the same point last year. Total liquidity was $12 billion and long-term debt was $273.3 million.
5. BJC merged with Kansas City, Mo.-based Saint Luke’s Health System in January 2024. The transaction created a 28-hospital system that provides care to to more than 6 million patients across Missouri, Illinois and Kansas.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
